Stockreport

Cognition Therapeutics Targets Faster DLB Psychosis Path as Zervimesine Nears Late-Stage Plans [Yahoo! Finance]

Cognition Therapeutics, Inc.  (CGTX) 
PDF Cognition Therapeutics (NASDAQ:CGTX) executives told investors at the Needham conference that the company is preparing to advance its once-daily oral candidate zervimes [Read more]